Johnson Midwest Financial’s Gilead Sciences GILD Stock Holding History

Johnson Midwest Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$4.2K	Buy	56 +1	+2%	+$77	0.01%	270
2023 Q2	$4.27K	Hold	55	–	–	﹤0.01%	272
2023 Q1	$4.56K	Buy	55 +1	+2%	+$83	0.01%	273
2022 Q4	$5K	Hold	54	–	–	0.02%	267
2022 Q3	$3	Buy	54 +1	+2%	+$63	0.01%	272
2022 Q2	$3K	Hold	53	–	–	﹤0.01%	250
2022 Q1	$3K	Buy	53 +1	+2%	+$64	﹤0.01%	232
2021 Q4	$4K	Hold	52	–	–	﹤0.01%	220
2021 Q3	$4K	Buy	52 +1	+2%	+$70	﹤0.01%	221
2021 Q2	$4K	Hold	51	–	–	﹤0.01%	213
2021 Q1	$3K	Buy	51 +1	+2%	+$64	﹤0.01%	220
2020 Q4	$3K	Buy	+50	New	+$3.02K	﹤0.01%	224

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Johnson Midwest Financial's GILD Position: Q3 2023 in Review

Johnson Midwest Financial increased its Gilead Sciences (GILD) stake by 1.8% in Q3 2023, buying an estimated $77 and bringing the position to 56 shares worth $4.2K. The position accounts for 0.01% of the portfolio, ranked #270.

Johnson Midwest Financial first reported a position in GILD in Q4 2020 and has held it in 12 quarters since. The position peaked at $5K in Q4 2022. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

Johnson Midwest Financial held 56 shares of Gilead Sciences worth $4.2K as of Q3 2023.
Johnson Midwest Financial bought 1 Gilead Sciences share in Q3 2023, an estimated $77.
Gilead Sciences made up 0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #270 holding.
Johnson Midwest Financial first reported a position in Gilead Sciences in Q4 2020 and has held it in 12 quarters since.
Johnson Midwest Financial's Gilead Sciences position peaked at $5K in Q4 2022.
1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.